tldrdailynews.com logo

Novavax Stock: Fluctuations, Soaring, Short Selling, and Trending with Trump's SPAC Partner

1 min read
Source: Benzinga
Novavax Stock: Fluctuations, Soaring, Short Selling, and Trending with Trump's SPAC Partner
Photo: Benzinga
TL;DR

Novavax shares fell over 8% after a previous surge in price following the FDA's Emergency Use Authorization for the company's updated protein-based COVID-19 vaccine for individuals aged 12 and older. The pullback in stock comes as the FDA has also approved updated vaccines from Moderna and Pfizer-BioNTech for the fall, all of which are expected to provide protection against current strains of the virus.

Topics:businessstock-market#covid-19-vaccine#fda#novavax#nvax#stock-market
Share this article
  1. Why Novavax Stock Fell Today - Novavax (NASDAQ:NVAX)  Benzinga
  2. Novavax (NVAX) Soars 8.2%: Is Further Upside Left in the Stock?  Yahoo Finance
  3. Short Sellers Are Betting Against Novavax (NVAX) Stock  InvestorPlace
  4. Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today? -  Benzinga
  5. View Full Coverage on Google News

Want the full story? Read the original reporting

Read on Benzinga